Veliparib
Veliparib (ABT-888) is a PARP inhibitor being investigated to treat non-small cell lung cancer, BRCA breast cancer and ovarian cancer.
Type of Molecule
Small MoleculeTarget
PARPProduct Type
New Indication| Potential Indication | Region | Phase (1, 2, 3, Submitted, Approved) |
|---|---|---|
| Ovarian Cancer | n/a |
Phase 3
|
| Breast Cancer | n/a |
Phase 3
|
| Lung Cancer | n/a |
Phase 3
|